Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Argen-X | Brussels | Healthcare | Biotechnology & Medical Research | €31.20B | 40.2x | 0.12 | €511 | 2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 43.5% Upside | Upgrade to Pro+ | |
UCB | Brussels | Healthcare | Pharmaceuticals | €27.66B | 25.9x | 0.13 | €145.40 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 48.9% Upside | Upgrade to Pro+ | |
Tubize-Fin | Brussels | Healthcare | Pharmaceuticals | €5.07B | 56.5x | 26 | €114.20 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Fagron | Brussels | Healthcare | Pharmaceuticals | €1.33B | 16.6x | 1.23 | €18.24 | 2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27.1% Upside | Upgrade to Pro+ | |
Ion Beam Applications | Brussels | Healthcare | Healthcare Equipment & Supplies | €303.49M | 38.6x | 0.27 | €10.40 | 3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nyxoah | Brussels | Healthcare | Healthcare Equipment & Supplies | €202.86M | -5.8x | 0.2 | €7.19 | 32.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ONWARD Medical BV | Brussels | Healthcare | Healthcare Equipment & Supplies | €174.95M | €3.95 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Hyloris | Brussels | Healthcare | Pharmaceuticals | €140M | -13.4x | €5.40 | 8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
AGFA Gevaert | Brussels | Healthcare | Healthcare Equipment & Supplies | €131.60M | -1.5x | -0.14 | €0.86 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sequana Medical | Brussels | Healthcare | Biotechnology & Medical Research | €46.65M | -1x | -0.06 | €0.88 | 4.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Biocartis Group NV | Brussels | Healthcare | Healthcare Equipment & Supplies | €27.24M | -0.3x | €0.29 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
European Medical Solutions | Brussels | Healthcare | Healthcare Providers & Services | €23.28M | -22x | 0.52 | €5.50 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Celyad | Brussels | Healthcare | Biotechnology & Medical Research | €19.06M | -3.3x | -0.06 | €0.46 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Biosenic | Brussels | Healthcare | Pharmaceuticals | €1.10M | -0.1x | -0 | €0.002 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oxurion | Brussels | Healthcare | Biotechnology & Medical Research | €364.20K | €0.10 | 4.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Personalized Nursing Services | Brussels | Healthcare | Healthcare Providers & Services | €245K | €0.40 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |